VistaGen Therapeutics (VTGN) Granted Japanese Patent for AV-101 for Treatment of Depression and Hyperalgesia - StreetInsider.com

Submitted by Anonymous (not verified) on Tue, 02/19/2019 - 13:37

VistaGen Therapeutics (VTGN) Granted Japanese Patent for AV-101 for Treatment of Depression and Hyperalgesia  StreetInsider.comNews and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.